← Back to catalogue

ImmunoCAP Thyroglobulin IgG Antibodies Control NLH

FDA UDI

Class I (US FDA UDI)

by Phadia GmbH

Identity

Trade Name
ImmunoCAP Thyroglobulin IgG Antibodies Control NLH FDA UDI
Generic Name
Plasma protein IVD, control FDA UDI
Device Name
Contains 2 vials of each IgG antibodies level (N: normal; L: low; H: high) for the ImmunoCAP Thyroglobulin method. FDA UDI
Model / Reference
10-9413-01 FDA UDI
Description
Contains 2 vials of each IgG antibodies level (N: normal; L: low; H: high) for the ImmunoCAP Thyroglobulin method. FDA UDI

Identifiers

Catalog Number
10-9413-01 FDA UDI
Primary DI / UDI-DI
07333066019611 FDA UDI
510(k) Number
K072661 FDA UDI
FDA Product Code
JJY FDA UDI
GMDN Term
Plasma protein IVD, control FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1660 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Plasma protein IVD, control

ImmunoCAP Thyroglobulin IgG Antibodies Control NLH by Phadia GmbH — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Plasma protein IVD, control.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Phadia GmbH

Sources (1)

  • FDA UDI 0d4ac001-4656-4be7-b2b9-200ef5d3104f 37 fields · synced May 30, 2026